ImmunoGen (IMGN) Receives Daily News Impact Rating of 0.21


Media coverage about ImmunoGen has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time.



from Biotech News